International Harmonization of Nomenclature and Diagnostic Criteria (INHAND): Nonproliferative and Proliferative Lesions of the Rabbit

Bradley A.E., Wancket L.M., Rinke M., Gruebbel M.M., Saladino B.H., Schafer K., Katsuta O., Garcia B., Chanut F., Hughes K., Nelson K., Himmel L., McInnes E., Schucker A., Uchida K.

2021
Journal of Toxicologic Pathology

View publication

Therapeutic Area

Other
Technology

Other
Categories

Preclinical development

Affiliations

Charles River Laboratories Edinburgh Ltd, Tranent, United Kingdom; Charles River Laboratories, Durham, NC, United States; Formerly Bayer AG, Germany; Experimental Pathology Laboratories Inc, Research Triangle ParkNC, United States; StageBio, Mason, OH, United States; Greenfield Pathology Services, Inc, Greenfield, IN, United States; Santen Pharmaceutical Co. Ltd, Nara, Japan; Sanofi, 1 Avenue Pierre Brosselette, Chilly-Mazarin, 91380, France; University of Cambridge, United Kingdom; Charles River Laboratories, Mattawan, MI, United States; Vanderbilt University Medical Center, Nashville, TN, United States; Syngenta, Jealotts Hill, Bracknell, Berkshire, United Kingdom; American Preclinical Services, LLC, 8945 Evergreen Blvd, Minneapolis, MN 55433, United States; The University of Tokyo, Tokyo, Japan

Related Publications

Enhancing Corneal Drug Penetration Using Penetratin for Ophthalmic Suspensions

Morofuji R.; Kudo K.; Honda T.; Kinugasa S.; Matsuo T.; Okabe K.

Use of Immunosuppression and the Risk of Subsequent Overall or Cancer Mortality

Kempen J.H.; Newcomb C.W.; Washington T.L.; Foster C.S.; Sobrin L.; Thorne J.E.; Jabs D.A.; Suhler E.B.; Rosenbaum J.T.; Sen H.N.; Levy-Clarke G.A.; Nussenblatt R.B.; Bhatt N.P.; Lowder C.Y.; Goldstein D.A.; Leiderman Y.I.; Acharya N.R.; Holland G.N.; Read R.W.; Dunn J.P.; Dreger K.A.; Artornsombudh P.; Begum H.A.; Fitzgerald T.D.; Kothari S.; Payal A.R.; Daniel E.; Gangaputra S.S.; Kaçmaz R.O.; Liesegang T.L.; Pujari S.S.; Khachatryan N.; Maghsoudlou A.; Suga H.K.; Pak C.M.; Helzlsouer K.J.; Buchanich J.M.

Exploring Cell-Penetrating Peptides as Penetration Enhancers in Eye Drop Formulations Using a Reconstructed Human Corneal Epithelial Model

Morofuji R.; Enomoto H.; Honda T.; Oyama Y.; Ishida R.; Kudo K.; Okabe K.

View all Other publications